chrisvoncsefalvay/vaers-outcomes huggingface dataset:
myocarditis; had three miscarriages following the pfizer vaccine; became pregnant while taking bnt162b2; This is a spontaneous report from a contactable consumer from a Pfizer sponsored Program. This consumer reported for a female patient (wife's friend). A pregnant female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection batch/lot number was not reported, expiration date was not reported), via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient historical vaccine included first dose of BNT162B2 for COVID-19 immunization. It was reported that, reporter stated that his wife's friend had three miscarriages following the Pfizer vaccine, the first one in the first trimester they could not find baby's heart beat. 2nd one had miscarriage a couple weeks after and then she conceived again and was in the hospital with myocarditis, her doctor said it was due to genetics and she lost the third one also. Reporter reports his wife's female friend had her first miscarriage, after the second vaccine and also reports that 82% of people, that got the vaccine experienced miscarriage and spontaneous abortion. Reporter states, his wife's friend had a total of 3 miscarriages and clarifies, that the first miscarriage occurred after both doses of the Pfizer Covid vaccine, reporter also states that she was also diagnosed with myocarditis and has spent hundreds of dollars on her medical bills. Reporter stated that this woman's doctor, said it was not caused from the vaccine, that it was genetic, and he did not report this to the VAERS website. The mother reported she became pregnant while taking BNT162B2. The reporter assessed the events as non-serious. The outcome of the events was unknown.  Information about lot/batch number has been requested.
Injection site itching; Redness at vaccination site; vaccination site swelling; 4-inches radius around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE REACTION (4-inches radius around the injection site), VACCINATION SITE ERYTHEMA (Redness at vaccination site) and VACCINATION SITE SWELLING (vaccination site swelling) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included ETHINYLESTRADIOL, FERROUS FUMARATE, NORETHISTERONE ACETATE (BLISOVI 24 FE) and Nexplanon insertion once every for Birth control.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced VACCINATION SITE REACTION (4-inches radius around the injection site). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE ERYTHEMA (Redness at vaccination site) and VACCINATION SITE SWELLING (vaccination site swelling). At the time of the report, VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE REACTION (4-inches radius around the injection site), VACCINATION SITE ERYTHEMA (Redness at vaccination site) and VACCINATION SITE SWELLING (vaccination site swelling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details were not reported by the reporter.
2 hrs p/immun, pt awake screaming and high pitched cry; screamed and cried most of night and next day; no elevated temp; by 11AUG94 pt was fine; mo wants only DT immun given;
Pt developed a fever of 102F-103F, 24 hours, post vax. The fever lasted 6 days (101F-102F). She had extreme body/muscle aches and was dx'd with pneumonia, 5 days, post vax. Followup states coughing and wheezing, treated with Tilade
Redness, mild swelling and itching in an area the size of 5 x 8 inches around the injection site. Lasting 1 week maybe longer. Applied warm packs to area.
Swelling/pain of lymph node under arm (armpit area).  Symptoms began later in the day and is still slightly swollen to date of this report (1/10/2023).   I understand this is a common side effect, but I felt it should be reported as this is my third booster 11/20/21 with the same reaction (swollen and painful lymph node under arm (armpit) that linger for about 10 days to 2 weeks.   Other less bothersome/shorter symptoms are extreme headache and body aches for about 1 day.
Patient left deltoid at injection site has a deep soreness. The pain radiates to neck to fingers. Causes the patient to feel nauseated. It was swollen and then went down but it does sometimes swells. It is not swollen or red right now. Patient took hydrocodone, tried alcohol and epsom salt but nothing works. Pain occurs every day. Patient cannot sleep on that arm.
Information has been received from a consumer concerning her son who was vaccinated with a dose of Varivax on an unspecified date. Subsequently, the patient experienced a bad case of chickenpox. It was unspecified if medical attention was sought. No outcome information was reported. Additional information has been requested.
mighty bad headaches, really really bad; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (mighty bad headaches, really really bad) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (mighty bad headaches, really really bad). At the time of the report, HEADACHE (mighty bad headaches, really really bad) outcome was unknown.            No concomitant medications were reported No treatment medications were reported   This case was linked to MOD-2021-404999 (Patient Link).
This spontaneous report as received from a healthcare worker refers to an unknown number of patients of unknown ages. On unknown dates, patients may have been administered GARDASIL that was exposed to -0.6 C for 4860 minutes, or 81 hours, on "10 or 11 occasions from 10/31 to 11/13" (year unspecified) (dose route and lot number were not reported). No concomitant medications were reported. No adverse effects reported. This is one of several reports received from the same source (MARRS#1311USA009162 and MARRS#1311USA009163). Additional information has been requested.
same day she started vomiting, 2nd day her eyes began to move rapidly, 3rd day she began losing her balance and twitching
Sore arm, red, tiny patches at the injection site and on the opposite arm; Sore arm, red, tiny patches at the injection site and on the opposite arm; Sore arm, red, tiny patches at the injection site and on the opposite arm; Sores inside mouth, canker sores; Chills; Sweating; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm, red, tiny patches at the injection site and on the opposite arm), INJECTION SITE REACTION (Sore arm, red, tiny patches at the injection site and on the opposite arm), ERYTHEMA (Sore arm, red, tiny patches at the injection site and on the opposite arm), APHTHOUS ULCER (Sores inside mouth, canker sores) and CHILLS (Chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Juvenile diabetes and Hypertension. Concomitant products included INSULIN for Type 1 diabetes mellitus.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm, red, tiny patches at the injection site and on the opposite arm), INJECTION SITE REACTION (Sore arm, red, tiny patches at the injection site and on the opposite arm), ERYTHEMA (Sore arm, red, tiny patches at the injection site and on the opposite arm), APHTHOUS ULCER (Sores inside mouth, canker sores), CHILLS (Chills) and HYPERHIDROSIS (Sweating). At the time of the report, PAIN IN EXTREMITY (Sore arm, red, tiny patches at the injection site and on the opposite arm), INJECTION SITE REACTION (Sore arm, red, tiny patches at the injection site and on the opposite arm), ERYTHEMA (Sore arm, red, tiny patches at the injection site and on the opposite arm), APHTHOUS ULCER (Sores inside mouth, canker sores), CHILLS (Chills) and HYPERHIDROSIS (Sweating) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Received J&J vaccine on 4/7/21 and received the Moderna booster on 1/6/22. Within 16 hours from taking the Moderna shot, my entire body was covered in hives (raised welts, red skin, itchiness all over body, with red dots in various places on my body) and my throat felt tight but I didn't have any trouble breathing. My lips and eyes were swollen.  I went to urgent care on 1/7/22 and they said that I likely had a latex allergic reaction from the bandaid that the pharmacy used after they administered the shot. They prescribed prednasone but said not to use it until Sunday, 1/9/22, as it would affect the effectiveness of the shot. Urgent care said to use benadryl for the hives.  The hives subsided during the day (itchy skin remained) but then started to return around 9 pm. On Saturday, 1/8/22, I woke up to worse hives, including swollen eyes, lips, and wrists. The raised welts were all over my body with red dots in some places (hands and neck). I called my allergist who said it was not a latex allergy but an immune reaction to the booster. He said to take the Prednasone immediately and take Allegra 180 mg/twice daily.  The hives have subsdided somewhat, but they are still there every morning when I wake up. I'm currently taking Allegra 180 mg/twice daily and Vitamin D. The allergist said that it could take a few weeks for the hives to disappear.
Received dose from expired vial; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received dose from expired vial) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received dose from expired vial). On 11-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Received dose from expired vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information were provided.
Red splotches on right arm below injection site starting with large circle, now goes down much of upper arm.  Very itchy.  Also, extreme irritability.
She says that since 11/2/22, she has been experiencing a dizzy sensation when she gets up from her bed at night/She says the room is spinning/she is woozy; Tiredness; Muscle weakness; Headache; didn't feel good; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 31st October 2022, the patient received the 1st dose of Shingrix. On 1st November 2022, 1 days after receiving Shingrix, the patient experienced tiredness, muscle weakness and headache. On 2nd November 2022, the patient experienced dizziness. In November 2022, the patient experienced feeling bad. On 2nd November 2022, the outcome of the tiredness and muscle weakness were recovered/resolved. On an unknown date, the outcome of the headache and dizziness were not recovered/not resolved and the outcome of the feeling bad was unknown.   It was unknown if the reporter considered the tiredness, muscle weakness, headache, dizziness and feeling bad to be related to Shingrix.     Additional Information: GSK receipt date: 11-NOV-2022 Reporters comment:The reporter was the patient, she received the first dose of shingrix in left arm The patient said that the next day she had tiredness, muscle weakness and a headache. She reports that the tiredness and muscle weakness went away the following day after on 2nd November 2022. Since 2nd November 2022, 2 days after vaccination, she had been experiencing a dizzy sensation when she gets up from her bed at night. She says the room was spinning and she was woozy and didn't feel good.  The patient still had the mild headache. No further information was reported. The reporter did not consent to follow-up.  The patient was unable to provide lot number or expiration date for the shingrix dose she received
not signs or symptoms reported. No other AE or PQC reported; a temperature excursion on ROTATEQ, ROTATEQ was administered; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender.  The patient's concomitant medication, pertinent medical history and drug allergies or reactions were not reported.   On 26-OCT-2021, the patient was vaccinated with improperly stored rotavirus vaccine, live, oral, pentavalent(ROTATEQ) (strength was not reported, lot # T040208, expiration date was 19-JUL-2022) 1 time dose, orally for prophylaxis (product storage error).         It was reported that the suspect vaccine was exposed to a temperature of 34.03 F for a time frame of 5 minutes (on 26-OCT-2021). There were no previous temperature excursions. No digital data logger was reported. There was no not signs or symptoms reported. No further adverse event (AE) information was provided (no adverse event).   This is one of the several reports reported by the same reporter.; Sender's Comments:  US-009507513-2111USA000689: US-009507513-2111USA000688:
Woke up this morning with swollen, and extremely tender right armpit area. It is visually swollen compared to the left and is very painful. I am under the assumption this is likely a swollen lymph node post second vaccination. I have taken ibuprofen in attempt to help with pain and inflammation but does not seem to be helping much at this time. I anticipate this will improve over time.
soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at the injection site) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (1 year ago). Concurrent medical conditions included Type 1 diabetes mellitus and Deaf.    On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (soreness at the injection site). At the time of the report, VACCINATION SITE PAIN (soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No information regarding corrective treatment was reported by the patient.
Patient reported  symptomatic heart palpitations after receiving the 2nd dose of the Pfizer SARS-CoV2 mRNA vaccine on 5/11/2021 at 1pm which lasted a few hours. She then presented to her urgent care clinic around 3pm and was transferred to the Hospital ED. She was found to be in sinus tachycardia to HR 140s-150s. Work-up as described below was largely unrevealing. Plan for TTE on this hospital admission. Overall believe that severe anxiety is a the driving factor behind her sinus tachycardia, and that the SARS-CoV2 vaccination was just coincidental in time course.
Patient came several months after the vaccination has a lump in his arm. He did not say when it came up, but was still there. He said there was no pain, redness, swelling or discomfort.
SYMPTOMS: Increased tingling in lower legs, increased skipped or irregular heart beats; increased tinnitus in left ear; NEW distortion/crackling sounds in left ear. TREATMENT: June 15, 2021 - hearing test revealed hearing loss in both ears, but more loss in left ear. After reporting to Dr. all of the symptoms I was experiencing after the vaccine, he thought they could be the result of an inflammatory response. He recommended steroids (oral or injected) to reduce the inflammation in my left ear. I opted for injected steroids. Returned a few days later for another hearing test, which revealed some improvement in the left ear. He recommended another treatment. Returned a few days later for another hearing test, which revealed no further improvement. He did not recommend a third treatment. Recommended a 6-month follow-up hearing test. OUTCOME: Some hearing in left ear was restored, but not fully. Increased tinnitus in left ear remains the same. Increased tingling and skipped/irregular heart beats lessened after about a 4-5 weeks. Distortion/crackling sound has subsided.
COVID Vaccine adverse reaction  9/6/21 Received second dose pfizer vaccine 1300.  Night of receiving vaccine began having electrifying zips of chest pain.  Lasting seconds at a time.   9/7/21 Woke up with severe back, hip, neck pain, flu like feeling, body aches, fatigue, febrile. Throughout the day began having constant chest pain with increased pain upon inspiration and exhalation along with shortness of breath during activity.  Was not able to lye flat or on left side without severe increased chest pain and difficulty breathing.  Slept in recliner on right side as it was the only position to get relief.   9/8/21 Back, hip and neck pain, flu like feeling, body aches, fever were gone but the chest pain and shortness of breath continued with worsening shortness of breath. Two events of dizziness.  Made doctor appointment at 1315.  Concern for PE or pericarditis and was sent to the ER from doctors office.  ER visit concluded inflammation and placed on 600mg ibuprofen 3x day for 2 weeks.    9/9/21 Continue to have chest pain and shortness of breath
Ringing in the ear after 2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing in the ear after 2nd shot) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In 2021, the patient experienced TINNITUS (Ringing in the ear after 2nd shot). At the time of the report, TINNITUS (Ringing in the ear after 2nd shot) outcome was unknown.            No Concomitant Drug details were reported.  No Treatment information was provided.
patient received an improperly stored dose of V ARIV AX; This spontaneous report was received from an office manager referring to a patient of unknown age and gender.   The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided.      On 03-AUG-2020, the patient received an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) (lot # S028920 has been verified to be valid, expiration date 16-SEP-2021) (dose and route of administration were not provided) for prophylaxis. The vaccine was reconstituted with properly stored diluent (manufacturer unknown).     The temperature excursion was: 22 Fahrenheit (F) degrees for 1 hour. No previous temperature excursions. The excursion call was made by a data logger.
Swelling in face, at eyes, (R) eye pain, HA, nausea, constipation, rash pain for 1 week.
27 year old man without prior history of smallpox vaccination reported rash (onset date of 26-June-2008 approx). Lab testing performed: anti-vaccinia IgM and IgG ELISA positive (by CDC). Case is linked to 3 other contact transmission cases all of which are members of the same facility.  There has been no identification of further transmission of any of these cases to family members or other close contacts. The source case has not yet been identified but the investigation is ongoing.
The author in the article discussed about the risk of anaphylaxis after vaccination in children and adults. This report refers to a 7-year- old male patient. Historic conditions included anaphylaxis and atopic dermatitis. Current conditions included allergy to egg and gelatin. Vaccination history included administration of trivalent influenza vaccine (TIV) (manufacturer and batch number: not reported) and other unspecified vaccines. No concomitant medication was reported. The patient was vaccinated with hepatitis A vaccine (manufacturer and batch number: not reported) along with varicella vaccine (other manufacturer, batch number: not reported) on an unknown date. Within 30 minutes to less than 60 minutes after vaccination the patient experienced angioedema, lips swelling, throat closure, red itchy eyes, cough, erythema, rash and vomiting. The patient was sent to the clinic. The emergency department doctor attributed vaccines as trigger for the events (vaccine triggered anaphylaxis). The patient was treated with epinephrine, oral antihistamine, oral H2 blocker, parenteral steroid, intravitreal injection (IVT) and bronchodilator. The patient was referred to an allergist. Final outcome of the events was reported as complete recovery. Seriousness of the events was not reported, but the event anaphylactic reaction was upgraded as medically significant based on Novartis Important Medical Events (NVS-IME) list. The author described the case as Brighton Level 1 of diagnostic certainty. The author concluded that the present study was based on a very large population receiving currently used vaccines and confirmed the rarity of post-vaccination anaphylaxis overall and after specific vaccines. Although anaphylaxis after immunization was rare; its immediate onset (usually within minutes) and life-threatening nature require that all personnel and facilities providing vaccinations have procedures in place for anaphylaxis management. Additional provider education concerning current recommendations for treatment and follow-up appears to be warranted. Upon review following corrections were done: Medical history of the patient was of allergies and anaphylaxis but the hypersensitivity to any particular product or its excipient was not reported. Event contraindication to vaccination was removed.; Reporter's Comments: Could not code IVT as treatment.
Nausea; Diarrhea; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  An adult male patient received bnt162b2 (BNT162B2), administration date Oct2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (prev dose product COVID 19,, prev dose brand Pfizer,, prev dose lot number Unknown, prev dose administration date: Mar2021, prev dose: dose number 2.), administration date: Mar2021, for covid-19 immunization; Bnt162b2 (prev dose product COVID 19,, prev dose brand Pfizer,, prev dose lot number Unknown,, prev dose administration date: Feb2021, prev dose: dose number 1.), administration date: Feb2021, for covid-19 immunization. The following information was reported: NAUSEA (non-serious) with onset Oct2021, outcome "recovered" (Oct2021), described as "Nausea"; DIARRHOEA (non-serious) with onset Oct2021, outcome "recovered" (Oct2021), described as "Diarrhea". Therapeutic measures were not taken as a result of nausea, diarrhoea.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.